Sunday, July 7, 2024
Mitochondrial Health

Clinical trial testing the SYMBYX light therapy helmet for Parkinson’s



The San Director of Research and Neurologist, Dr Geoffrey Herkes (MBBS, PhD, FRACP) led a team of scientific researchers on a clinical trial testing the efficacy of the SYMBYX Neuro (red light helmet) for Parkinson’s symptoms in Sydney in 2022/23. In this video, Dr Herkes and co-lead research investigator, Dr Ann Liebert (PhD), explain the trial and discuss how light therapy can work as a complementary treatment modality in managing Parkinson’s symptoms.

SYMBYX Biome is a Sydney, Australia based med-tech company developing and testing innovative light therapy devices for intractable conditions such as Parkinson’s, Fibromyalgia, arthritis, chronic pain, peripheral neuropathy, etc.

The device tested in this clinical trial is the SYMBYX Neuro. https://symbyxbiome.com/products/symbyx-neuro

www.symbyxbiome.com

#photobiomodulation #dopamine #gutbrainhealth #infrared #redlighttherapy #lightherapy #parkinsons

source

Similar Posts